1. Funamoto M, Sunagawa Y, Katanasaka Y, Kato T, Funada J, Ajiro Y, Komiyama M, Akao
M, Yasoda A, Yamakage H, Satoh-Asahara N, Wada H, Ikeda Y, Morimoto T, Hasegawa K.
Effects of high-absorption curcumin for the prevention of hypertensive heart disease: adouble-blind, placebo-controlled, randomized clinical study. Eur Heart J (Open). 2022; 2:
1-9.
2. Yoshida T, Nakamura A, Funada J, Amino M, Shimizu W, Fukuzawa M, Watanabe S,Hayashi T, Yamashita T, Okumura K, Akao M. Efficacy and Safety of Edoxaban 15 mg
According to Renal Function in Very Elderly Patients with Atrial Fibrillation: A Subanalysisof the ELDERCARE-AF Trial. Circulation. 2022 Mar 1; 145(9): 718–720.
3. Wada H, Shinozaki T, Suzuki M, Sakagami S, Ajiro Y, Funada J, Matsuda M, Shimizu M,
Takenaka T, Morita Y, Yonezawa K, Matsubara H, Ono Y, Nakamura T, Fujimoto K,
Ninomiya A, Kato T, Unoki T, Takagi D, Wada K, Wada M, Iguchi M, Yamakage H,Kusakabe T, Yasoda A, Shimatsu A, Kotani K, Satoh-Asahara N, Abe M, Akao M,Hasegawa K, for the EXCEED-J Study Investigators.Impact of Chronic Kidney Disease on
the Associations of Cardiovascular Biomarkers with Adverse Outcomes in Patients withSuspected or Known Coronary Artery Disease: The EXCEED-J Study.

J Am Heart

Assoc. 2022; 11: e023464.
4. Iguchi M, Wada H, Shinozaki T, Suzuki M, Ajiro Y, Matsuda M, Koike A, Koizumi T,Shimizu M, Ono Y, Takenaka T, Sakagami S, Morita Y, Fujimoto K, Yonezawa K, YoshidaK, Ninomiya A, Nakamura T, Funada J, Kajikawa Y, Oishi Y, Kato T, Kotani K, Abe M,Akao M, Hasegawa K, for the PREHOSP‐CHF Study Investigators.

Soluble vascularendothelial growth factor receptor 2 and prognosis in patients with chronic heart failure.
ESC Heart Fail. 2021 Oct; 8(5): 4187–4198.
5. Wada H, Suzuki M, Matsuda M, Ajiro Y, Shinozaki T, Sakagami S, Yonezawa K, Shimizu
M, Funada J, Takenaka T, Morita Y, Nakamura T, Fujimoto K, Matsubara H, Kato T, UnokiT, Takagi D, Wada K, Wada M, Iguchi M, Masunaga N, Ishii M, Yamakage H, Kusakabe T,Yasoda A, Shimatsu A, Kotani K, Satoh-Asahara N, Abe M, Akao M, Hasegawa K; ANOX
Study Investigators. Impact of smoking status on growth differentiation factor 15 andmortality in patients with suspected or known coronary artery disease: The ANOX Study.

JAm Heart Assoc. 2020; Nov 10: e018217.
6. Wada H, Suzuki M, Matsuda M, Ajiro Y, Shinozaki T, Sakagam Si, Yonezawa K, Shimizu M,Funada J, Takenaka T, Morita Y, Nakamura N, Fujimoto K, Matsubara H, Kato T, Unoki T,Takagi D, Wada K, Wada M, Iguchi M, Masunaga N, Ishii M, Yamakage H, Kusakabe T,Yasoda A, Shimatsu A, Kotani K, Satoh-Asahara N, Abe M, Akao M, Hasegawa K. Distinct
Characteristics of VEGF-D and VEGF-C to predict mortality in patients with suspected or
known coronary artery disease. J Am Heart Assoc. 2020; 9: e015761.
7. Takakado M, Takata Y, Yamagata F, Yaguchi M, Hiasa G, Sato S, Funada J, Kawazu S,Osawa H. Simple and non-invasive screening method for diabetes based on myoinositol
levels in urine samples collected at home.

BMJ Open Diabetes Res Care. 2020; 8(1):e000984.
8. Ono K, Wada H, Satoh-Asahara N, Inoue H, Uehara K, Funada J, Ogo A, Horie T, Fujita M,
Shimatsu A, Hasegawa K; ABLE-MET Investigators.

Effects of metformin on left

ventricular size and function in hypertensive patients with type 2 diabetes mellitus: results ofa randomized, controlled, multicenter, phase IV trial. Am J Cardiovasc Drugs. 2020; 20(3):283–293.
9. Wada H, Suzuki M, Matsuda M, Ajiro Y, Shinozaki T, Sakagami S, Yonezawa K, Shimizu
M, Funada J, Takenaka T, Morita Y, Nakamura T, Fujimoto K, Matsubara H, Kato T, Unoki
T, Takagi D, Ura S, Wada K, Iguchi M, Masunaga N, Ishii M, Yamakage H, Shimatsu A,Kotani K, Satoh-Asahara N, Abe M, Akao M, Hasegawa K; for the ANOX Study
Investigators. VEGF-C and mortality in patients with suspected or known coronary arterydisease. J Am Heart Assoc. 2018; 7: e010355.
10. Fujii A, Inoue K, Nagai T, Nishimura K, Uetani T, Suzuki J, Funada J, Okura T, Higaki J,

Ogimoto A.

Clinical utility of atrial electromechanical conduction time measured withspeckle tracking echocardiography after catheter ablation in patients with atrial fibrillation:
A validation study with electroanatomical mapping. Echocardiography. 2016; 33(9): 13171325.
11. Fujii A, Inoue K, Nagai T, Uetani T, Nishimura K, Suzuki J, Funada J, Okura T, Higaki J,
Ogimoto A.

Clinical significance of peripheral endothelial function for left atrial bloodstagnation in nonvalvular atrial fibrillation patients with low-to-intermediate stroke risk.
Circ J. 2016; 80: 2117-2113.
12. Yukumi S, Ichiki H, Funada J, Suzuki H, Morimoto M, Fujita T, Izumi N, Abe M.
Postcardiac injury syndrome following vascular interventional radiofrequency ablation forparoxysmal atrial fibrillation. Respiratory medicine case report. 2015; 15: 89-91.
13. Kurata A, Kawaguchi N, Kido T, Inoue K, Suzuki J, Ogimoto A, Funada J, Higaki J,Miyagawa M, Vembar M, Mochizuki T.

Qualitative and quantitative assessment ofadenosine triphosphate stress whole-heart dynamic myocardial perfusion imaging using 256slice computed tomography. PLoS One. 2013 Dec 23; 8(12): e83950.
14. Inoue K, Okayama H, Nishimura K, Nagai T, Suzuki J, Ogimoto A, Saito M, Yoshii T, Hiasa
G, Sumimoto T, Funada J, Shigematsu Y, Hamada M, Higaki J. Impact of septal curvatureon regional strain in patients with hypertrophic cardiomyopathy.

Circ J. 2013; 77(4): 1040-1045.
15. S Inaba, H Okayama, J Funada, H Higashi, M Saito, T Yoshii, G Hiasa, T Sumimoto, YTakata, K Nishimura, K Inoue, A Ogimoto, J Higaki. Impact of type 2 diabetes on serialchanges in tissue characteristics of coronary plaques -an integrated backscatter intravascularultrasound analysis. Eur Heart J. Cardiovasc Imaging. 2012 Sep; 13(9):717-723.
16. K Nishimura, H Okayama, K Inoue, M Saito, T Yoshii, G Hiasa, T Sumimoto, S Inaba, AOgimoto, J Funada, J Higaki.

Direct measurement of radial strain in the inner-half layer ofthe left ventricular wall in hypertensive patients. J Cardiol. 2012 Jan; 59(1): 64-71.
17. K Inoue, H Okayama, K Nishimura, M Saito, T Yoshii, G Hiasa, T Sumimoto, S Inaba, JSuzuki, A Ogimoto, J Funada, J Higaki. Right ventricular septal pacing preserves global
left ventricular longitudinal function in comparison with apical pacing: analysis is of speckle
tracking echocardiography.

Circ J. 2011; 75 1609-1615.

18. M Saito, H Okayama, T Yoshii, G Hiasa, T Sumimoto, S Inaba, K Nishimura, K Inoue, AOgimoto, Y Shigematsu, J Funada, M Hamada M, J Higaki. J.

Myocardial fibrosis

attenuates the effect of cibenzoline on left ventricular diastolic function in patients withhypertrophic cardiomyopathy. Cardiovasc Pharmacol. 2011 Feb; 57(2): 207-212.
19. T Nagai, H Okayama, K Nishimura, K Inoue, J Suzuki, A Ogimoto, T Ohtsuka, G Hiasa, TSumimoto, J Funada, J Higaki.

Initial Japanese experience and long-term follow-up witha new active fixation coronary sinus lead, the StarFix 4195.

J Cardiol cases. 2010; 1: e176-179.
20. K Nishimura, H Okayama, K Inoue, M Saito, T Yoshii, G Hiasa, T Sumimoto, S Inaba, AOgimoto, T Ohtsuka, J Funada, Y Shigematsu, J Higaki.

Usefulness of the MOSAIC(measurement of stenosis by aliasing coronary flow) method using transthoracic color
Doppler echocardiography in unstable angina patients. Int J Cardiol. 2011 Sep 1; 151: 170174.
21. M Saito, H Okayama, T Yoshii, G Hiasa, T Sumimoto, S Inaba, K Nishimura, K Inoue, AOgimoto, T Ohtsuka, J Funada, Y Shigematsu, J Higaki. The differences in left ventricular
torsional behavior between patients with hypertrophic cardiomyopathy and hypertensive
heart disease. Int J Cardiol. 2011 Aug 4; 150: 301-306.
22. S Inaba, H Okayama, J Funada, H Hashida, G Hiasa, T Sumimoto, Y Takata, K Nishimura,K Inoue, A Ogimoto, T Ohtsuka, J Higaki. Relationship between smaller calcifications andlipid-rich plaques on integrated backscatter-intravascular ultrasound. Int J Cardiol. 2010;145(2):347-348.
23. K Inoue, H Okayama, K Nishimura, A Ogimoto, T Ohtsuka, M Saito, G Hiasa, T Yoshii, TSumimoto, J Funada, J Higaki. J. Right ventricular pacing from the septum avoids theacute exacerbation in left ventricular dyssynchrony and torsional behavior seen with pacingfrom the apex. Am Soc Echocardiogr. 2010; 23(2): 195-200.
24. H Hashida, J Funada, N Morioka, T Iwata. The lurking potential of tangential forces: acase of an arteriovenous shunt developed by percutaneous coronary intervention for the septalbranch.

J Cardiol 2010; 1: e1-e5.

25. A Fujii, J Funada, N Morioka, H Hashida, T Iwata, T Higaki.

A case of pulmonary stenosis

after a repair for tetralogy of Fallot treated with percutaneous pulmonary valvuloplasty usinga triple-balloon technique. J Cardiol 2010; 55: 130-134.